• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁丙诺啡用于慢性疼痛:系统评价。

Buprenorphine for Chronic Pain: a Systemic Review.

机构信息

Center for Interventional Pain and Spine, Wilmington, DE, USA.

出版信息

Curr Pain Headache Rep. 2018 Oct 5;22(12):83. doi: 10.1007/s11916-018-0732-2.

DOI:10.1007/s11916-018-0732-2
PMID:30291571
Abstract

PURPOSE OF REVIEW

The purpose of this review is to evaluate and explain our current understanding of the clinical use of buprenorphine in the treatment of chronic pain.

RECENT FINDINGS

There has been few high-quality, unbiased studies performed on the use of buprenorphine in the treatment of chronic pain. Buprenorphine is an effective and safe analgesic that is tolerated at least as well, if not better, than other opioids. Given its safety and mechanistic advantages, the authors believe there is an important role for buprenorphine in the treatment of chronic pain severe enough to warrant the use of an opioid analgesic. Though data is lacking for superiority in chronic pain states, the other advantages of the molecule make it the preferential first-line opioid for around-the-clock pain in our practice.

摘要

目的综述

本综述旨在评估和解释我们目前对丁丙诺啡在慢性疼痛治疗中的临床应用的理解。

最近的发现

很少有高质量、无偏见的研究针对丁丙诺啡在慢性疼痛治疗中的应用进行。丁丙诺啡是一种有效且安全的镇痛药,其耐受性至少与其他阿片类药物一样好,如果不是更好的话。鉴于其安全性和机制优势,作者认为丁丙诺啡在治疗疼痛剧烈需要使用阿片类镇痛药的慢性疼痛方面具有重要作用。虽然在慢性疼痛状态下缺乏优越性的数据,但该分子的其他优势使其成为我们实践中治疗全天候疼痛的首选一线阿片类药物。

相似文献

1
Buprenorphine for Chronic Pain: a Systemic Review.丁丙诺啡用于慢性疼痛:系统评价。
Curr Pain Headache Rep. 2018 Oct 5;22(12):83. doi: 10.1007/s11916-018-0732-2.
2
Buprenorphine in the Treatment of Chronic Pain.丁丙诺啡用于慢性疼痛的治疗。
Phys Med Rehabil Clin N Am. 2020 May;31(2):195-204. doi: 10.1016/j.pmr.2020.02.001. Epub 2020 Mar 13.
3
Buprenorphine buccal film for chronic pain management.丁丙诺啡颊膜用于慢性疼痛管理。
Pain Manag. 2020 Jul;10(4):213-223. doi: 10.2217/pmt-2020-0013. Epub 2020 May 12.
4
Recommending buprenorphine for pain management.推荐丁丙诺啡用于疼痛管理。
Pain Manag. 2019 Jan 1;9(1):13-16. doi: 10.2217/pmt-2018-0069. Epub 2018 Dec 3.
5
Buprenorphine for chronic pain.丁丙诺啡用于慢性疼痛。
J Pain Palliat Care Pharmacother. 2013 Dec;27(4):402-5. doi: 10.3109/15360288.2013.847522. Epub 2013 Nov 18.
6
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.治疗慢性疼痛:以丁丙诺啡选择为中心的临床研究概述。
Drugs. 2018 Aug;78(12):1211-1228. doi: 10.1007/s40265-018-0953-z.
7
Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone.比较丁丙诺啡与超低剂量纳洛酮丁丙诺啡的镇痛效力和副作用。
J Addict Med. 2012 Jun;6(2):118-23. doi: 10.1097/ADM.0b013e31824fceca.
8
Treating Chronic Pain with Buprenorphine-The Practical Guide.《丁丙诺啡治疗慢性疼痛实用指南》。
Curr Treat Options Oncol. 2021 Nov 18;22(12):116. doi: 10.1007/s11864-021-00910-8.
9
Buprenorphine transdermal system utilization.丁丙诺啡透皮贴剂的使用情况。
Postgrad Med. 2017 Jan;129(1):81-86. doi: 10.1080/00325481.2017.1267537. Epub 2016 Dec 15.
10
Buprenorphine: considerations for pain management.丁丙诺啡:疼痛管理的考量因素
J Pain Symptom Manage. 2005 Mar;29(3):297-326. doi: 10.1016/j.jpainsymman.2004.07.005.

引用本文的文献

1
Pain Management Strategies for Patients Receiving Extended-Release Buprenorphine for Opioid Use Disorder: A Scoping Review.接受长效丁丙诺啡治疗阿片类物质使用障碍患者的疼痛管理策略:一项范围综述
Subst Use. 2025 Jun 14;19:29768357251343612. doi: 10.1177/29768357251343612. eCollection 2025 Jan-Dec.
2
16. Pain in chronic pancreatitis.16. 慢性胰腺炎中的疼痛。
Pain Pract. 2025 Apr;25(4):e70030. doi: 10.1111/papr.70030.
3
Dysphagia as a Missing Link Between Post-surgical- and Opioid-Related Pneumonia.术后肺炎和阿片类药物相关性肺炎之间缺失的环节:吞咽困难。

本文引用的文献

1
Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures.丁丙诺啡制剂:接受手术或介入性疼痛程序的患者围手术期管理的临床最佳实践策略建议。
Pain Physician. 2018 Jan;21(1):E1-E12.
2
Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.丁丙诺啡透皮贴剂的有效性和耐受性:一项针对亚洲中重度慢性肌肉骨骼疼痛患者的多中心、前瞻性、开放标签研究。
BMC Musculoskelet Disord. 2017 Aug 4;18(1):337. doi: 10.1186/s12891-017-1664-4.
3
Lung. 2024 Apr;202(2):179-187. doi: 10.1007/s00408-024-00672-8. Epub 2024 Mar 27.
4
Nociceptive Flexion Reflex Threshold is No Suitable Marker for Diagnosing Opioid-Induced Hyperalgesia.伤害性屈曲反射阈值并非诊断阿片类药物诱导性痛觉过敏的合适指标。
J Pain Res. 2024 Mar 14;17:1067-1076. doi: 10.2147/JPR.S421841. eCollection 2024.
5
Serotonin therapies for opioid-induced disordered swallow and respiratory depression.用于治疗阿片类药物引起的吞咽和呼吸抑制障碍的 5-羟色胺治疗药物。
J Appl Physiol (1985). 2024 Apr 1;136(4):821-843. doi: 10.1152/japplphysiol.00509.2023. Epub 2024 Feb 22.
6
The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis.HOPE 联盟试验的设计和基线特征旨在减轻血液透析患者的疼痛和阿片类药物使用。
Contemp Clin Trials. 2024 Jan;136:107409. doi: 10.1016/j.cct.2023.107409. Epub 2023 Dec 10.
7
Buprenorphine for Chronic Pain Management: a Narrative Review.丁丙诺啡用于慢性疼痛管理:叙述性综述。
Curr Pain Headache Rep. 2023 Dec;27(12):811-820. doi: 10.1007/s11916-023-01185-4. Epub 2023 Oct 28.
8
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.
9
Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report.丁丙诺啡/纳洛酮采用微剂量方案诱导治疗慢性疼痛急性发作:一例报告。
Can J Pain. 2019 Apr 25;3(1):79-84. doi: 10.1080/24740527.2019.1599279. eCollection 2019.
10
Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.丁丙诺啡用于慢性疼痛:一种比传统阿片类药物更安全的替代品。
Health Psychol Res. 2021 Aug 6;9(1):27241. doi: 10.52965/001c.27241. eCollection 2021.
Buprenorphine transdermal system utilization.
丁丙诺啡透皮贴剂的使用情况。
Postgrad Med. 2017 Jan;129(1):81-86. doi: 10.1080/00325481.2017.1267537. Epub 2016 Dec 15.
4
Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study.丁丙诺啡口腔贴片用于有阿片类药物使用经历的中重度慢性下腰痛患者的疗效及耐受性:一项3期、富集入组、随机撤药研究的结果
Pain. 2016 Nov;157(11):2517-2526. doi: 10.1097/j.pain.0000000000000670.
5
Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain.经皮丁丙诺啡缓解神经病理性疼痛:糖尿病周围神经病理性疼痛的随机、双盲、平行分组、安慰剂对照试验。
Diabetes Care. 2016 Sep;39(9):1493-500. doi: 10.2337/dc16-0123. Epub 2016 Jun 16.
6
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
7
Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers.健康志愿者中单剂量和多剂量丁丙诺啡口腔膜的药代动力学评估。
Clin Ther. 2016 Feb;38(2):358-69. doi: 10.1016/j.clinthera.2015.12.016. Epub 2016 Jan 21.
8
Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain.口腔含服丁丙诺啡对中度至重度慢性下腰痛的阿片类药物初治患者的疗效和耐受性
Postgrad Med. 2016 Jan;128(1):1-11. doi: 10.1080/00325481.2016.1128307. Epub 2015 Dec 22.
9
Buprenorphine for treating cancer pain.丁丙诺啡用于治疗癌痛。
Cochrane Database Syst Rev. 2015 Mar 31;2015(3):CD009596. doi: 10.1002/14651858.CD009596.pub4.
10
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials.丁丙诺啡透皮贴剂改善中重度慢性下腰痛患者的睡眠质量并减少睡眠障碍:两项随机对照试验的结果
Pain Pract. 2016 Mar;16(3):345-58. doi: 10.1111/papr.12281. Epub 2015 Jan 20.